A Los Angeles landscape at golden hour

Propoxyphene

Darvocet: withdrawn from market and what to know

Withdrawn from the US market for cardiac toxicity at ordinary doses. If you still have some in a cabinet, that is the reason not to take it.

Prefer to call? Our admissions line is (747) 888-3000, answered by an admissions clinician. Clinical review of this updated version is pending.

  • Licensed by the California Department of Health Care Services. License 190896AP · Certification 190896BP, verifiable on the DHCS registry.
  • Joint Commission accredited. Behavioral Health Care and Human Services, ID 622659.
  • PPO insurance and private pay. We do not accept Medicare, Medicaid, or Medi‑Cal.
  • Named clinical leadership. Our medical director: Dr. Adnan E. Khoury, MD, dual-trained in internal medicine and psychiatry.

Quick answer

Darvocet combined propoxyphene, a weak opioid, with acetaminophen. It was withdrawn from the US market after evidence that propoxyphene caused serious cardiac rhythm changes at therapeutic doses. Anyone still holding old supplies should not take them, and anyone still dependent needs a plan rather than a gap.

If this is an emergency

Call 911 if someone is unresponsive, having a seizure, breathing slowly or irregularly, or confused with a high fever. For a mental health or suicidal crisis, call or text 988 to reach the Suicide & Crisis Lifeline, available 24 hours a day. This website is not monitored in real time.

Key takeaways

A person seated in a quiet, well-lit room
Stock photography. Not a patient, clinician or facility of this network.
  • Darvocet was propoxyphene combined with acetaminophen. Darvon was propoxyphene alone.
  • It was withdrawn from the US market following evidence of serious cardiac rhythm changes at ordinary therapeutic doses.
  • The cardiac risk was not confined to overdose, which is what distinguished this from a typical opioid safety concern.
  • The acetaminophen component carried the same liver risk as any combination analgesic.
  • Old supplies still turn up in medicine cabinets. They should be disposed of rather than taken.

What it isWhy it was withdrawn

Most opioids are dangerous in overdose and reasonably safe at prescribed doses. Propoxyphene was unusual: evidence accumulated that it caused changes to cardiac electrical conduction at ordinary therapeutic doses, not only in overdose. That is a different category of problem, and it is why the drug was removed rather than restricted.

Propoxyphene is a weak opioid analgesic withdrawn from the US market after evidence of cardiac conduction effects at therapeutic doses.

What the evidence showed

Studies indicated that propoxyphene affected cardiac electrical conduction in ways associated with serious arrhythmia, and that this occurred at doses people were routinely prescribed rather than only in overdose. Combined with a weak analgesic effect — it was never a strong painkiller — the risk-benefit calculation no longer held. The FDA requested withdrawal and the product left the market.

The medicine cabinet problem

Withdrawn drugs do not vanish from households. Darvocet was prescribed very widely for years, and old bottles still turn up. Someone finding one and taking it for back pain is exposing themselves to a cardiac risk that a regulator judged unacceptable, for a weak analgesic effect. If you find old propoxyphene, dispose of it — pharmacies and law enforcement take-back programs accept unused medication.

Effects and signsWhat to know

This page is short because the practical guidance is short.

Propoxyphene considerations. Market withdrawal followed cardiac findings at therapeutic doses.
AreaWhat appliesNotes
Market statusWithdrawn from the US market at FDA requestOld supplies still exist in households
CardiacConduction changes associated with serious arrhythmiaOccurred at therapeutic doses, not only overdose
AnalgesiaWeakPart of why the risk-benefit no longer held
AcetaminophenPresent in Darvocet; absent in DarvonSame liver arithmetic as other combination products
DependenceGenuine opioid dependence with sustained useWithdrawal is standard opioid withdrawal
DisposalTake-back programs accept unused medicationDo not keep or take old supplies
If still dependentNeeds a plan rather than an abrupt gapStandard opioid treatment applies

If you are still dependent on it

A drug leaving the market does not end anyone’s dependence. If you have been obtaining propoxyphene from remaining supplies or from outside a pharmacy, the situation is the same one described on the prescription painkiller page: an ending supply plus withdrawal plus an accessible illicit market, which in Los Angeles largely means fentanyl. Get an assessment before the supply runs out rather than after.

What replaced it

Nothing replaced it directly, because it was never a strong analgesic and its niche was largely served by other options. If you were taking Darvocet for chronic pain and lost access when it was withdrawn, that is a pain management conversation rather than a search for an equivalent tablet. Non-opioid options and a proper pain reassessment are the reasonable starting point.

Not sure whether this has become a problem? One conversation will tell you.

Talk to our admissions team

What to doWhat to do

Three short answers depending on your situation.

If you found old tablets

Dispose of them

Take-back programs accept unused medication. Do not take them.

If you still take it

Speak to a prescriber

Cardiac risk applies at ordinary doses, not just overdose.

If you are dependent

Get assessed now

Before the supply ends, not after.

The system-level picture is on prescription painkillers, the combination-product liver issue on hydrocodone, and treatment on opioid addiction treatment.

A small group seated together in conversation
Stock photography. Not a patient, clinician or facility of this network.

Insurance and costWhat it costs, and how to check us

Cost is driven by level of care and length of stay rather than by which substance brought you here. We publish ranges by level of care rather than quoting only on the phone, and your figure is confirmed in writing after a free verification and before admission. The published bands sit on what treatment costs, and cost information is never used to slow a medically urgent admission.

Carriers we work with

  • Aetna
  • Anthem Blue Cross
  • Blue Cross Blue Shield
  • Cigna
  • United Healthcare

Before you hand a family member to any program, verify it. We accept PPO insurance from the major commercial carriers and private payment. We do not accept Medicare, Medicaid, or Medi‑Cal — we say so up front rather than waste your time. If that is your coverage, the SAMHSA treatment locator will find a provider who accepts it. Otherwise, start a free verification or read the full carrier list.

Licensing you can check

Licensed by the State Department of Health Care Services: license 190896AP (Woodland Hills residential). Certified by the State Department of Health Care Services: certification 190896BP (Tarzana outpatient and IOP). Verify any California license directly with DHCS.

The clinical team

Our medical director, Dr. Adnan E. Khoury, MD, is dual-trained in internal medicine and psychiatry. Every clinician page carries the clinician's full name, credentials, training, board certifications, languages spoken and the patient populations they work with, all verifiable through state licensing boards. Meet the clinical team.

Darvocet — the full guide library

12 guides

Each guide below answers one question completely — how to recognize it, what it does to health, what withdrawal involves, and how to help someone who is not asking for help.

The bottom line

If you have found an old bottle of Darvocet in a cabinet, the right move is the take-back bin rather than the medicine drawer. It was withdrawn for a reason that applies at normal doses.

Evidence to use when planning care

Compare assessment, the clinical approach, mental health support and continuing care when choosing a program. A facility name, advertised duration or attractive setting does not by itself establish that the service fits your needs. See NIDA’s questions to ask about treatment.

Independent treatment directories help people find and compare services. Confirm the provider’s current services, professional qualifications and appointment availability directly rather than treating a directory listing as a guarantee. See SAMHSA’s treatment-finding resources.

Ask about benefits, authorization, payment options and the expected cost before committing to care. Insurance and payment information on a general page does not confirm your individual coverage or a quoted price. See SAMHSA’s guide to paying for treatment.

Frequently asked questions

Why was Darvocet taken off the market?

Because evidence indicated propoxyphene caused changes to cardiac electrical conduction associated with serious arrhythmia, and that this happened at ordinary therapeutic doses rather than only in overdose. Combined with a weak analgesic effect, the risk-benefit calculation no longer held and the FDA requested withdrawal.

For darvocet addiction, is it still available anywhere?

Not through legitimate US channels. Old supplies still exist in households, which is the practical concern — it was prescribed very widely for years and bottles turn up. Anything obtained outside a pharmacy carries the additional risk that it may not be what it claims.

For darvocet addiction, I found some old tablets. Can I take them?

No. Dispose of them through a pharmacy or law enforcement take-back program. The cardiac risk that prompted withdrawal applies at ordinary doses, and the analgesic benefit was weak, so there is no version of this trade that makes sense.

What is the difference between Darvon and Darvocet?

Darvon was propoxyphene alone. Darvocet combined propoxyphene with acetaminophen, which added the same liver considerations that apply to any acetaminophen-containing analgesic. Both contained the propoxyphene that prompted the withdrawal.

I am still dependent on it. What should I do?

Get an assessment before your supply runs out rather than after. A drug leaving the market does not end dependence, and the dangerous pattern is withdrawal plus an accessible illicit market. Medication for opioid use disorder applies here as to any opioid dependence.

What replaced it?

Nothing directly, because it was never a strong analgesic and its niche was largely covered by other options. If you lost pain control when it was withdrawn, that is a pain management conversation rather than a search for an equivalent tablet — non-opioid options and a proper reassessment are the sensible starting point.

Was the cardiac risk only in overdose?

No, and that is what made this different from a typical opioid safety concern. The conduction effects were observed at therapeutic doses. Most opioids are dangerous in overdose and reasonably safe as prescribed; propoxyphene was not, which is why removal rather than restriction was the response.

How is dependence treated?

As opioid dependence, with the same approved medications and behavioral treatment, plus attention to any cardiac effects and to the acetaminophen exposure if the combination product was used at volume. Verification is free and creates no obligation. We do not accept Medicare, Medicaid or Medi-Cal.

When you are ready, we are here. Free, confidential, and no commitment.

Talk to our admissions team

How this page was built and reviewed

The market withdrawal and its basis in cardiac conduction findings at therapeutic doses follow FDA action and published evidence. The distinction between Darvon and Darvocet reflects product composition. Disposal guidance directs to established take-back programs. No dosing information is published, and no replacement medication is recommended.

Clinical review of this updated version is pending. The linked sources support general education; an individual assessment is needed for personal care recommendations.

References

  1. Centers for Disease Control and Prevention. Overdose prevention and naloxone. https://www.cdc.gov/
  2. National Institute on Drug Abuse. Prescription opioids drug facts. https://nida.nih.gov/
  3. MedlinePlus, U.S. National Library of Medicine. Opioid medications. https://medlineplus.gov/
  4. American Society of Addiction Medicine. National practice guideline for the treatment of opioid use disorder. https://www.asam.org/
  5. California Department of Health Care Services. Licensed and certified SUD facility verification. https://www.dhcs.ca.gov/individuals/Pages/SUD-Licensed-Certified.aspx
Medical disclaimer This page is for information only and is not a substitute for professional medical advice, diagnosis, or treatment. Substance use disorder is a chronic medical condition; outcomes vary by person, and nothing here promises a particular result. Always talk with a qualified clinician about your situation. Read our the full disclaimer.